{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:18:52Z","timestamp":1783124332942,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.addbeh.2011.01.004","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T07:09:08Z","timestamp":1294988948000},"page":"636-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness"],"prefix":"10.1016","volume":"36","author":[{"given":"Daryle E.A.","family":"Deering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janie","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Douglas","family":"Sellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheridan","family":"Pooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2011.01.004_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09595239800186961","article-title":"The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list","volume":"17","author":"Adamson","year":"1998","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0010","series-title":"The effectiveness of methadone maintenance treatment: Patients, programmes, services, and outcome","author":"Ball","year":"1991"},{"issue":"3","key":"10.1016\/j.addbeh.2011.01.004_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0379-0738(87)90074-0","article-title":"The illicit preparation of morphine and heroin from pharmaceutical products containing codeine: Homebake laboratories in New Zealand","volume":"34","author":"Bedford","year":"1987","journal-title":"Forensic Science International"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3109\/10826080009148239","article-title":"Quality improvement for methadone maintenance treatment","volume":"35","author":"Bell","year":"2000","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.1995.tb02231.x","article-title":"Investigating the influence of treatment philosophy on outcome of methadone maintenance","volume":"90","author":"Bell","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/10826089609045820","article-title":"Attitudes and beliefs of staff working in methadone maintenance clinics","volume":"31","author":"Caplehorn","year":"1996","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0035","series-title":"New Zealand Treatment Research Monograph, Alcohol Drugs and Addiction. Research Proceedings from the Cutting Edge Conference","first-page":"7","article-title":"Methadone prescribing in New Zealand: A national survey","author":"Clunie","year":"2003"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0040","series-title":"A report for the Ministry of Health","article-title":"Intravenous opioid dependence in New Zealand","author":"Deering","year":"2008"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0045","series-title":"Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors","first-page":"1109","article-title":"Illicit drug use","author":"Degenhardt","year":"2004"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0050","series-title":"New Zealand treatment research monograph, alcohol, drugs and addiction. Research proceedings from the cutting edge conference","first-page":"19","article-title":"Minimal methadone treatment: A pilot methadone treatment developed by Northland A & D Service and delivered by general practitioners","author":"Dunn","year":"2003"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1081\/JA-120002807","article-title":"Canadian illicit opiate users' views on methadone and other opiate prescription treatment: An exploratory qualitative study","volume":"37","author":"Fischer","year":"2002","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0060","series-title":"Heroin in the Age of Crack Cocaine","first-page":"118","article-title":"\u201cHustling\u201d within the clinic: Consumer perspectives on methadone maintenance treatment","author":"Hunt","year":"1998"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0065","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1176\/appi.ps.52.9.1223","article-title":"Relationship between counselling rapport and drug treatment outcomes","volume":"52","author":"Joe","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/16066359409005200","article-title":"The patients' charter: Drug users' views on the \u201cideal\u201d methadone programme","volume":"4","author":"Jones","year":"1994","journal-title":"Addiction Research"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0075","first-page":"347","article-title":"Methadone maintenance treatment (MMT): A review of historical and clinical issues","volume":"67","author":"Joseph","year":"2000","journal-title":"The Mount Sinai Journal of Medicine"},{"issue":"4","key":"10.1016\/j.addbeh.2011.01.004_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.37464\/2009.264.1751","article-title":"Nurse practitioners in drug and alcohol: Where are they?","volume":"26","author":"Ling","year":"2009","journal-title":"Australian Journal of Advanced Nursing"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09595230020029419","article-title":"New trends in opiate pharmacotherapy","volume":"20","author":"Ling","year":"2001","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0095","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.addbeh.2006.09.008","article-title":"An investigation of stigma in individuals receiving treatment for substance abuse","volume":"32","author":"Luoma","year":"2007","journal-title":"Addictive Behaviours"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1360-0443.2005.01012.x","article-title":"Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring","volume":"100","author":"McLellan","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/09595230801935706","article-title":"Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment","volume":"27","author":"Madden","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0110","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3109\/10826089909039410","article-title":"Programme quality effects on patient outcomes during methadone maintenance: A study of 17 clinics","volume":"34","author":"Magura","year":"1999","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0115","series-title":"Consumer and peer roles in the addiction sector","author":"Matua Raki","year":"2010"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0120","series-title":"New Zealand Treatment Research Monograph, Alcohol, Drugs and Addiction. Research Proceedings from the Cutting Edge Conference","first-page":"35","article-title":"Interim methadone provision programme (IMPP) in Dunedin \u2014 Preliminary results","author":"Mellor","year":"2005"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0125","series-title":"Opioid substitution treatment New Zealand practice guidelines","author":"Ministry of Health","year":"2003"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0130","series-title":"National Guidelines: Interim methadone prescribing","author":"Ministry of Health","year":"2007"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0135","series-title":"Practice guidelines for opioid substitution treatment in New Zealand","author":"Ministry of Health","year":"2008"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0140","series-title":"South Island methadone project report","year":"2001"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0145","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective Medical Treatment of Opiate Addiction","volume":"280","author":"National consensus development panel on effective medical treatment of opiate addiction","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0150","first-page":"33","article-title":"Drug users' views of prescribed methadone","volume":"5","author":"Neale","year":"1998","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1360-0443.1995.tb03788.x","article-title":"The impact of a brief motivational intervention with opiate users attending a methadone programme","volume":"90","author":"Saunders","year":"1995","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.addbeh.2011.01.004_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archpsyc.63.1.102","article-title":"A randomized controlled trial of interim methadone maintenance","volume":"63","author":"Schwartz","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","article-title":"Mortality from overdose among injecting drug users recently released from prison: Database linkage study","volume":"316","author":"Seaman","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0175","series-title":"Delivery of treatment for people with opioid dependence in New Zealand: Options and recommendations: A commissioned paper for the Ministry of Health, New Zealand","author":"Sellman","year":"1996"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0180","series-title":"Paper presented at the International Opioid Overdose Symposium, Sydney, Australia","article-title":"Death as a result of consuming opioid drugs: A New Zealand perspective","author":"Sellman","year":"1997"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09595230412331289419","article-title":"What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?","volume":"23","author":"Sheerin","year":"2004","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/j.addbeh.2011.01.004_bb0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/09595230701829538","article-title":"Barriers to, and incentives for, the transfer of opioid-dependent people on methadone maintenance treatment from secondary care to primary health care","volume":"27","author":"Sheridan","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jurban\/79.4.571","article-title":"Beliefs about methadone in an inner-city methadone clinic","volume":"79","author":"Stancliff","year":"2002","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0195","first-page":"7","article-title":"A preventative ethics approach to methadone maintenance programmes","author":"Townshend","year":"2001","journal-title":"New Zealand Bioethics Journal"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0200","series-title":"Peer-based addiction recovery support: History, theory, practice and scientific evaluation","author":"White","year":"2009"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1081\/JA-120002808","article-title":"Dialogue. Methadone and heroin prescription: Babies and bathwater","volume":"37","author":"Wodak","year":"2002","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0210","first-page":"75","article-title":"Methadone advocacy: The voice of the patient","volume":"68","author":"Woods","year":"2001","journal-title":"The Mount Sinai Journal of Medicine"},{"key":"10.1016\/j.addbeh.2011.01.004_bb0215","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2105\/AJPH.81.9.1185","article-title":"A randomized trial of an interim methadone maintenance clinic","volume":"81","author":"Yancovitz","year":"1991","journal-title":"American Journal of Public Health"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460311000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460311000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:32:33Z","timestamp":1759689153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460311000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0306460311000104"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2011.01.004","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2011.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}